Balingit, Kemberly M.

HRN: 27-38-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2025
CEFUROXIME 750MG (VIAL)
08/04/2025
08/10/2025
IV
750mg
Q12
Uti
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines